Recently, Hai Hong Holdings, a medical listed company, pre-released its first smart medical product in Haikou. It is reported that the "Haihong-made" smart medical diagnostic system features more than Watson, in addition to diagnostic treatment, but also as a professional library of doctors, patient self-diagnosis, health management, medical insurance and other tools. The first domestically-produced diagnostic robot was born with the powerful “Haihong†system. Recently, Hai Hong Holdings, a medical listed company, pre-released its first smart medical product in Haikou, which can help doctors diagnose diseases and recommend treatment programs. Kang Hong, president of Hai Hong Holdings, said: “Many large hospitals frequently implement tens of millions of IT systems and hardware every year, but they cannot find professional tools to assist clinicians in clinical diagnosis and treatment.†Internationally, Haihong’s intelligent diagnostic systems are The target product is the IBM Watson robot. After upgrading in 2016, Watson can answer professional questions through natural language to help doctors diagnose cancer, which is 4 times more accurate than primary doctors. "Haihong made" smart medical diagnostic system features more than Watson, in addition to diagnostic treatment, but also as a professional library for doctors, patient self-diagnosis, health management, medical insurance and other tools, do this reason It is the Haihong system that lays the foundation for PBM business and big data, and combines the three major knowledge bases of clinical diagnosis and treatment path, pharmacy, and medical insurance policies and regulations. The reason why this system was developed is that Haihong Holding Shangguan Yongqiang judged that the current medical and health industry has entered the era of artificial intelligence from the information age, and 2017 will become China's “first year of smart medical treatmentâ€, resulting in a blowout-type explosion. As early as in 2009, the National Health and Family Planning Commission issued the “Management Specification for Artificial Intelligence Assistant Diagnostic Technologies (Trial)â€. Based on the PBM business, Haihong Holdings has now formed a “PBM+AI†(medical welfare management + artificial intelligence) pattern. In the future, the company's new profit points will appear in many dimensions such as PBM, commercial insurance, artificial intelligence, and patients. The Chinese version of Watson with more functions like Google AlphaGo can be played like a human, and the Haihong smart medical system can also be treated like a doctor. Shangguan Yongqiang, vice president of the company, defines it as a tool for decision-making aids in diagnosis and treatment: using medical artificial intelligence technology to provide assisted diagnosis and decision-making and recommended optimal treatment programs for clinicians throughout the course of diagnosis and treatment, and to provide clinical treatment methods and diagnosis and treatment results of cooperation experts for physicians Reference for reference. Yao Bin, an attending physician at the Second People’s Hospital of Shenzhen City, said that he particularly hopes to have such an auxiliary diagnosis system in his daily work. He once tried to construct an auxiliary diagnosis and treatment system, but was limited by the amount of data and technology and failed to succeed. . "Intelligent diagnostic aid system can reduce the misdiagnosis rate." Zhang Yunjiang, deputy general manager of Haihong Holding's Great Health Division, said that once the doctor signs a contract with Haihong Smart Medical System, it means that a robot is provided to help doctors complete the diagnosis and interactive learning. process. This auxiliary diagnostic system is still a blank in the country. Internationally, only IBM Watson robots, Enlitic, etc. can compete with it. At the end of December 2016, IBM Watson landed a consultation center at the Zhejiang Provincial Hospital, which means that the intelligent diagnostic system has entered commercial applications in China. However, the Haihong system has more functions and is more suitable for the Chinese medical system. As early as the end of 2014, Haihong Holdings was preparing an artificial neural network intelligent diagnosis and treatment optimization system based on clinical evidence-based medicine. PBM business and big data laid the foundation for medical artificial intelligence. Among them, evidence-based medicine includes at least three major knowledge bases of Drgs clinical path, pharmacy, and medical insurance policies and regulations. Therefore, doctors can obtain the diagnosis and treatment advice, as well as the approximate cost and medical insurance of patients under various treatment options. Reimbursement. This is closely related to the big data and PBM that Haihong Holdings has accumulated for many years. In addition to diagnosis and treatment, Haihong intelligent system is also a doctor's library, which contains clinical guidelines, medication instructions and product guidance, subdivided professional academic literature, medical insurance management policies, the National Health and Family Planning Commission publicized typical examples, doctors' cases. Communication tools and other commonly used clinical data. Chinese-made smart robots naturally have Chinese characteristics, such as the contract management tools applicable to grading diagnosis and treatment: in response to the policy of “encouraging family doctors to sign contractsâ€, on the basis of third-party handling, the participants and doctors are encouraged to establish long-term service contract relationships. And promote medical insurance filing. Not only doctors, but patients can also benefit from this medical intelligence system. If you are sick, you don’t ask Baidu anymore. Before that, patients often listened to non-professional networks and advertising, caused erroneous medications, and made unreasonable medical treatment. To this end, Haihong intelligent medical system can measure the patient's input information, clinical routines, and probabilistic measures, speculate on their health status, and display clinical diagnostic pathways and publicized treatment standards. While assisting patient self-diagnosis, it can also provide accessible medical resource reference selection based on factors such as patient health status, medical insurance payment ability, and geographical medical conditions, so as to maximize the use of peripheral convenient medical resources and reduce cross-level and cross-regional medical treatment. The personal burden and wasted medical resources. At the same time, Haihong smart medical system can seamlessly connect patients' "new health" products and provide patients with personal health alarms, smart medical assistants, and health welfare consultants. The reason why this system was developed is that Shangguan Yongqiang judged that the current medical and health industry has entered the era of artificial intelligence from the information age. "The application of artificial intelligence in medical applications has included virtual assistants (a siri), drug numeration, disease screening (Google deep mind) and auxiliary diagnosis and treatment (Watson)." Shangguan Yongqiang told the 21st Century Business Herald: " It can be said that 2017 is the first year of smart medical services.†Different from IBM Watson, PBM and Big Data are based on the same foundation. The “Haihong†intelligent diagnostic system is based on its PBM business that has been plowing for many years. At the end of 2014, Haihong Holdings was preparing an intelligent diagnosis and treatment optimization system based on artificial neural networks for clinical evidence-based medicine. The PBM business laid the foundation for medical artificial intelligence. PBM stands for Pharmaceutical Welfare Management, which refers to coordinating insurance institutions, drug companies, pharmacies, hospitals (doctors), and patients' medical practitioners. Without affecting the effectiveness of the medical treatment, PBM can affect the participation of the parties involved in the treatment of medical services. The purpose of reducing the total cost of medical care. One of PBM's core businesses is medical insurance review, which is equivalent to installing an electronic eye during a doctor's visit to monitor whether there is drug abuse or over-diagnosis in a medical prescription, like an electronic eye on a highway. As of June last year, the coverage of Haihong Holding's medical insurance control fee business expanded to nearly 200 cities in 24 provinces/municipalities across the country. The review results publicized the feedback system more than 8000 on-line hospitals, 2 million licensed physicians, and served with more people Eight hundred million people have accumulatively exceeded 16 billion units in the number of trials. The third-party payment review service of the Medicare Fund has covered 6 cities including Zhanjiang, Yueyang, Zunyi, Chengdu, Shantou and Yingtan with a population of 90 million. Kang Hong, President of Hai Hong Holdings, announced that “The PBM (Pharmacy Welfare Management) Business reflects Hai Hong's service capabilities and company value in the medical industry. The continuous investment of the “Haihong Smart Medical Project†will become the basis for Hai Hong's deep cultivation of PBM. Strategic focus." In June 2015, the company signed an agreement with the Zhanjiang Social Insurance Fund Management Bureau to open the Zhanjiang Model 2.0, marking the PBM business entering a comprehensive “housekeeper modelâ€. The Zhanjiang Social Insurance Fund Management Bureau appointed the company as a professional service organization to conduct audits, payments, evaluations, and insurer services for the Zhanjiang Medical Insurance Fund. It broke through the scope of the medical insurance fund audit and control fees and fully undertook the management of medical insurance funds. Under the upgraded “housekeeper†model, the PBM business was upgraded to intelligent management models such as fund management assistance, quality assessment, settlement review, and big data management, and was specifically divided into “medical insurance intelligence auxiliary auditâ€, “smart auditâ€, and “Internet + Three categories of Medicare big data application services. However, in the process of PBM development, the company upholds the Internet company's thinking “when it wants to get aheadâ€, first encircling the ground, acquiring and accumulating data flow, and then converting traffic to income. Throughout the country, with the control of medical insurance funds as a starting point, it signed contracted third-party management services with local medical insurance funds. For instance, on October 15 this year, the company issued a plan for additional issuance and plans to raise 2.5 billion yuan for the construction of a real-time intelligent audit platform project. Although no profit has yet been generated, the PBM business has accumulated critical government resources, endowed the health insurance fund with refined management capabilities, participated in drug pricing to create a medical insurance payment price base, occupied the commanding heights in the insurance sector and relied on the pharmaceutical e-commerce business. Therefore, although the PBM business has not brought too much performance support to Haihong Holdings in the past two years, it can be predicted that once the PBM business enters the charging stage after a large-scale business coverage, it will become the cornerstone and highlight of the company's future performance. In addition, profit points that can be seen also include commercial insurance. At the commercial side, Haihong Holdings has formed strategic partnerships with 13 commercial insurance institutions. It will provide TPA product design, underwriting and renewal services for commercial and commercial organizations; and it will benefit from sharing benefits and sharing risks. Fundamentally solve the difficult problem of commercial insurance profitability. At the C-side, Haihong Holdings also actively constructs a new health care network, cooperates with hospitals and pharmaceutical companies, and uses e-commerce platforms and APPs to provide special services such as appointments, chronic disease management, and home delivery. At present, there are about 160 contracted hospitals nationwide and about 50 contracted production companies. PBM + AI Industry Platform Appears From the end of 2016 to 2017, China's artificial intelligence medical products have also come out one after another. When a reporter asked about the difference between “Haihong Smart Medical Project†and other current smart medical companies, “Haihong Smart Medical Project The person in charge explained that there are a large number of medical imaging intelligent identifications, medical big data mining, mother-infant care robots, genetic engineering artificial intelligence, intelligent guidance diagnostic robots and other products emerging in the industry. In terms of technology implementation, there are a few common points, but due to differences in target customers, market fundamentals, and business models, there are significant changes in overall product design, technology path selection, system architecture, and operating model. At present, the "Haihong smart medical project" fills the gap in the domestic clinical assistant tool and has not yet found the same type of product. As mentioned above, the foundation of “Haihong Smart Medical Project†lies in PBM, the accumulation of clinical knowledge base, the convenience of access to knowledge by medical expert consultants, frequent trial and error in medical institutions, model iteration, and the deep sharing of domestic and foreign learning technologies. , saving a lot of time and intellectual costs for the product generation cycle. It is reported that Haihong Holdings will continue to refine the medical payment service based on the existing PBM business. The new artificial intelligence strategy will also include hospitals, outpatient centers, doctors groups, clinics, pharmacies, pharmaceutical manufacturers, and distribution and distribution. The medical industry chain institutions, such as enterprises and commercial insurance, share services with various industry sectors. 
For example, DeepMind, a company affiliated with AlphaGo’s Google company, invented the company's core medical division, DeepMindHealth, and NHS (UK Medicare) announced again that it would build a new artificial intelligence clinical information system within five years. At the same time, the Trinorder-X, a health sensor application released by Google on the Android platform, will record personal retinal scan data, blood samples, and respiratory parameters in cooperation with the mobile phone. The sensor group supports 54 biological information collections and can quantitatively measure almost all human characterizations. , To achieve real-time health monitoring, provide a good basis for the payer to timely health interventions, maintain health, reduce overall spending. “In foreign countries, the integration between PBM and other artificial intelligence technology companies is totally natural. Foreign industrial capital has been deployed for a long time. China has just started. Haihong Holdings builds medical industry service sharing and application distribution based on PBM+AI dual engines. The platform will graft the payment side service to other partners, supplemented by long-term cooperative arrangements for benefit sharing, and ultimately lead to a mutually beneficial win-win situation, said Kang Jian.
For example, DeepMind, a company affiliated with AlphaGo’s Google company, invented the company's core medical division, DeepMindHealth, and NHS (UK Medicare) announced again that it would build a new artificial intelligence clinical information system within five years. At the same time, the Trinorder-X, a health sensor application released by Google on the Android platform, will record personal retinal scan data, blood samples, and respiratory parameters in cooperation with the mobile phone. The sensor group supports 54 biological information collections and can quantitatively measure almost all human characterizations. , To achieve real-time health monitoring, provide a good basis for the payer to timely health interventions, maintain health, reduce overall spending. “In foreign countries, the integration between PBM and other artificial intelligence technology companies is totally natural. Foreign industrial capital has been deployed for a long time. China has just started. Haihong Holdings builds medical industry service sharing and application distribution based on PBM+AI dual engines. The platform will graft the payment side service to other partners, supplemented by long-term cooperative arrangements for benefit sharing, and ultimately lead to a mutually beneficial win-win situation, said Kang Jian.
What Does it Mean for Market Players?
- Chemical Companies
Chemical companies tend to look at the consumer electronics sector as a lucrative segment, given the supply of raw materials to cell manufacturers aimed at developing batteries for gadgets and devices. An entirely new market opportunity requires a commercial strategy as to how much investment is safe to make in EVs. In addition, frequent amendments in the specifications of EVs also put the confidence of chemical companies at test. However, partnering with lithium-ion battery manufacturers will make it easier for chemical companies to supply raw materials on a demand basis.
- Battery Manufacturers
As applications of lithium-ion batteries move into a new dimension, battery manufacturers have both, pressure and opportunity on the horizon. With drastic improvements in the demand for lithium-ion batteries ascending from the automotive sector, manufacturers need to prioritize their investments and production facilities as per the RoI potential of the region that they are operating in. Since leading battery manufacturers take a cost competitive and innovation-driven approach, product diversification can be a good bet.
- Automakers
The automotive industry has been undergoing a seismic shift, with electricity being the new default fuel. This has inspired automakers to redefine their business models based on current and future sustainability implications. With a high pick in the number of EV manufacturers, stiff competition can be tackled only by standing out in the market, which will shift focus towards the 'comfort' and 'aesthetics' of electric cars. To achieve this, automakers will seek customized auto parts, which can be achieved through backward integration, acquisition of a battery manufacturer, or a joint collaboration.
Solar System Batteries,Solar Panel Battery Cost,Enphase Battery Cost,Solar Battery Storage Price
Shenzhen Sunbeam New Energy Co., Ltd , https://www.sunbeambattery.com